FDA Inspection 1113285 — FXM Clinical Research Miami LLC
The FDA completed an inspection of FXM Clinical Research Miami LLC on Dec 10, 2019 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 10, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional details
Clinical BA/BE